0.2400
+0.0400
+(20.00%)
At close: January 10 at 3:58:55 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-332.5740
-1,419.7610
-6,101.7450
-3,477.6610
-5,975.0270
Investing Cash Flow
--
--
--
171.1160
--
Financing Cash Flow
18.3120
1,439.4310
6,018.0460
3,268.0390
6,208.9140
End Cash Position
63.3270
155.4160
135.7460
219.4450
257.9510
Issuance of Capital Stock
18.3120
1,504.7360
3,451.9480
839.9230
8,765.2940
Issuance of Debt
--
--
2,750.0000
2,500.0000
2,069.2790
Repayment of Debt
--
--
--
-175.0000
-3,918.8000
Free Cash Flow
-332.5740
-1,419.7610
-6,101.7450
-3,477.6610
-5,975.0270
12/31/2020 - 11/28/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BLAB.CN Britannia Life Sciences Inc.
0.0850
0.00%
ONCO.CN Onco-Innova
1.2000
0.00%
MDMA.CN Pharmala Biotech Holdings Inc.
0.3100
+16.98%
MIR.V MedMira Inc.
0.1300
0.00%
RKV.V Rakovina Therapeutics Inc.
0.1750
-2.78%
BCT.TO BriaCell Therapeutics Corp.
0.5900
-3.28%
MYND.CN MYND Life Sciences Inc.
0.0950
+35.71%
VXL.V Vaxil Bio Ltd.
0.0100
0.00%
BIOV.CN BioVaxys Technology Corp.
0.0600
-7.69%
IBO.V Universal Ibogaine Inc.
0.0250
+25.00%